About 2 results found for searched term "JNJ-61803534" (0.127 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M21144 | JNJ-61803534 | Others |
| JNJ-61803534 is an orally active RORgt inhibitor, JNJ-61803534 is an oral clinical candidate that is well tolerated in humans up to 200 mg and has shown PD. | ||
| M29017 | JNJ-61803534 | ROR |
| JNJ-61803534 is a potent and orally active RORγt inverse agonist with an IC50 of 9.6 nM. JNJ-61803534 has anti-inflammatory activity. JNJ-61803534 inhibits IL-17A production in human CD4+ T cells under Th17 differentiation conditions. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
